 |
|
|
|
|
|
|
| Article 1 to 9 out of 9 concerning National Institutes of Health (NIH)
|
-
Stanford Scientists Pinpoint Key Proteins in Blood Stem Cell Replication
(10 Oct 2008)
A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules’ function spurs the normally resting cells to begin ...
-
Existing Anti-Obesity Drugs May Be Effective Against Flu, Hepatitis and HIV
(06 Oct 2008)
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published in the journal Nature Biotechnology.Metabolism ...
-
Agilent Technologies Tools Used to Derive New Type of Mouse Embryonic Stem Cell that Shares Key Features of Human Embryonic Stem
(30 Jul 2007)
Using a variety of Agilent Technologies genomics tools, researchers at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and the University of Oxford, U.K., have achieved a major milestone in ...
-
Affymetrix Selected to Genotype More Than 9,000 Framingham Heart Study Samples
(07 Sep 2006)
SHARE Project to Help Identify Genetic Variants Associated With Heart, Lung, Blood and Sleep Disorders
Affymetrix Inc. announced that it has been selected by the SHARE (SNP Health Association REsource) project for a large-scale whole-genome association study. As part of the project, Affymetrix will collaborate with the National Heart, Lung, and Blood ...
-
Celera Genomics Receives NIH Grant to Develop and Commercialize Avian Flu Diagnostic Test
(24 Aug 2006)
Celera Genomics, an Applera Corporation business, announced that the National Institutes of Health (NIH) has awarded Celera approximately $900,000 to develop and commercialize an in vitro diagnostic (IVD) test for the highly pathogenic influenza ...
-
Corgenix to develop diagnostic tests for bioterrorism agents under multi-million dollar NIH contract
(14 Nov 2005)
Company expands presence into BioDefense
Corgenix Medical Corporation, in partnership with Tulane University, the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and two corporate partners, will develop and manufacture improved diagnostic tests for viral hemorrhagic ...
-
Affibody and National Cancer Institute, NIH, to Develop Molecular In Vivo Imaging Agents for Detection of Cancer
(09 Nov 2005)
Affibody AB announced a cooperative agreement with the NCI/NIH on the development of conjugates with Affibody® molecules to be used for in vivo imaging of cancers over-expressing HER2. The collaboration is a Cooperative Research and Development ...
-
Affymetrix Microarrays Uncover Genetic Mutations in Embryonic Stem Cells Approved for Federally-Funded Research
(06 Sep 2005)
Affymetrix Inc. announced that a research group led by scientists at Johns Hopkins School of Medicine and the NIH used Affymetrix GeneChip(R) microarrays to discover that eight of the stem cell lines approved for federally-funded research have ...
-
NIH Awards $4.2 Million Grant to Scientists at Scripps Research to Speed DNA Sequencing Technologies
(10 Aug 2005)
A team of scientists at The Scripps Research Institute in California and Oxford University in England have been awarded a $4.2 million five-year grant to conduct basic science aimed at speeding the rate at which the next generation of DNA sequencing ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon